These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24468412)

  • 21. In vitro study of the variable effects of proton pump inhibitors on voriconazole.
    Niece KL; Boyd NK; Akers KS
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5548-54. PubMed ID: 26124167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of monoglyceride lipase by proton pump inhibitors: investigation using docking and in vitro experiments.
    Dahabiyeh LA; Abu-Rish EY; Taha MO
    Pharmacol Rep; 2020 Apr; 72(2):435-442. PubMed ID: 32048247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enantioselective disposition of omeprazole, pantoprazole, and lansoprazole in a same Brazilian subjects group.
    Cassiano NM; Oliveira RV; Bernasconi GC; Cass QB
    Chirality; 2012 Apr; 24(4):289-93. PubMed ID: 22344845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Proton pump inhibitors, a family of drugs in continuous expansion].
    Pellicano R
    Minerva Gastroenterol Dietol; 2000 Dec; 46(4):231-41. PubMed ID: 19320085
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
    Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockage of intracellular proton extrusion with proton extrusions with proton pump inhibitor induces apoptosis in gastric cancer.
    Yeo M; Kim DK; Park HJ; Cho SW; Cheong JY; Lee KJ
    Cancer Sci; 2008 Jan; 99(1):185. PubMed ID: 18224727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of Ligand-Efficient Scaffolds for the Design of Novel
    Auletta S; Caravan W; Persaud JK; Thuilot SF; Brown DG; Parkin DW; Stockman BJ
    ACS Omega; 2019 Oct; 4(14):16226-16232. PubMed ID: 31592163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
    Devault KR
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel.
    Siller-Matula JM; Spiel AO; Lang IM; Kreiner G; Christ G; Jilma B
    Am Heart J; 2009 Jan; 157(1):148.e1-5. PubMed ID: 19081411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liquid chromatographic resolution of proton pump inhibitors including omeprazole on a ligand exchange chiral stationary phase.
    Ha JJ; Choi HJ; Jin JS; Jeong ED; Hyun MH
    J Chromatogr A; 2010 Oct; 1217(41):6436-41. PubMed ID: 20828702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton pump inhibitors: new drugs and indications.
    Mears JM; Kaplan B
    Am Fam Physician; 1996 Jan; 53(1):285-92. PubMed ID: 8546054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pantoprazole does not influence the antiplatelet effect of clopidogrel-a whole blood aggregometry study after coronary stenting.
    Neubauer H; Engelhardt A; Krüger JC; Lask S; Börgel J; Mügge A; Endres HG
    J Cardiovasc Pharmacol; 2010 Jul; 56(1):91-7. PubMed ID: 20410834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton pump inhibitors versus
    Brilhante RS; da Rocha MG; de Oliveira JS; España JD; Pereira VS; Scm Castelo-Branco D; A Pereira-Neto W; Sidrim JJ; A Cordeiro R; Rocha MF
    Future Microbiol; 2019 Apr; 14():489-497. PubMed ID: 31033338
    [No Abstract]   [Full Text] [Related]  

  • 34. Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicity.
    Hashioka S; Klegeris A; McGeer PL
    Exp Neurol; 2009 May; 217(1):177-83. PubMed ID: 19232345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes: a comparison with other proton pump inhibitors.
    Masubuchi N; Hakusui H; Okazaki O
    Drug Metab Dispos; 1997 May; 25(5):584-9. PubMed ID: 9152597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct Measurement of Nucleoside Ribohydrolase Enzyme Activities in
    Stockman BJ; Ventura CA; Deykina VS; Khayan Lontscharitsch N; Saljanin E; Gil A; Canestrari M; Mahmood M
    Anal Chem; 2023 Mar; 95(12):5300-5306. PubMed ID: 36917470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential inhibitory effects of proton pump inhibitors on the metabolism and antiplatelet activities of clopidogrel and prasugrel.
    Chen CH; Yang JC; Uang YS; Lin CJ
    Biopharm Drug Dispos; 2012 Jul; 33(5):278-83. PubMed ID: 22623337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normal and polar-organic-phase high-performance liquid chromatographic enantioresolution of omeprazole, rabeprazole, lansoprazole and pantoprazole using monochloro-methylated cellulose-based chiral stationary phase and determination of dexrabeprazole.
    Dixit S; Dubey R; Bhushan R
    Biomed Chromatogr; 2014 Jan; 28(1):112-9. PubMed ID: 23616104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rabeprazole: a second-generation proton pump inhibitor in the treatment of acid-related disease.
    Pallotta S; Pace F; Marelli S
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):509-22. PubMed ID: 19072398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of N-aryl isothioureas as a novel class of gastric H(+) /K(+) -ATPase inhibitors.
    Ma C; Wu A; Wu Y; Ren X; Cheng M
    Arch Pharm (Weinheim); 2013 Dec; 346(12):891-900. PubMed ID: 24301963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.